117 related articles for article (PubMed ID: 26513752)
1. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer.
Scavo MP; Gentile E; Wolfram J; Gu J; Barone M; Evangelopoulos M; Martinez JO; Liu X; Celia C; Tasciotti E; Vilar E; Shen H
Colloids Surf B Biointerfaces; 2015 Dec; 136():694-703. PubMed ID: 26513752
[TBL] [Abstract][Full Text] [Related]
2. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
[TBL] [Abstract][Full Text] [Related]
4. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
6. Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC.
Faux MC; Weinstock J; Gogos S; Prato E; Azimpour AI; O'Keefe R; Cathcart-King Y; Garnham AL; Ernst M; Preaudet A; Christie M; Putoczki TL; Buchert M; Burgess AW
Cancer Res Commun; 2022 Feb; 2(2):66-77. PubMed ID: 36860494
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
[TBL] [Abstract][Full Text] [Related]
8. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
9. Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis.
Femia AP; Soares PV; Luceri C; Lodovici M; Giannini A; Caderni G
BMC Cancer; 2015 Sep; 15():611. PubMed ID: 26335331
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.
Jacoby RF; Cole CE; Hawk ET; Lubet RA
Gastroenterology; 2004 Sep; 127(3):838-44. PubMed ID: 15362039
[TBL] [Abstract][Full Text] [Related]
12. Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.
Gerner EW
Biochem Soc Trans; 2007 Apr; 35(Pt 2):322-5. PubMed ID: 17371270
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
14. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
Mariadason JM; Corner GA; Augenlicht LH
Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
[TBL] [Abstract][Full Text] [Related]
15. CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development.
Lee YS; Choi D; Kim NY; Yang S; Jung E; Hong M; Yang D; Lenz HJ; Hong YK
Int J Cancer; 2014 Jul; 135(1):232-7. PubMed ID: 24338666
[TBL] [Abstract][Full Text] [Related]
16. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Katdare M; Kopelovich L; Telang N
Ann N Y Acad Sci; 2001 Dec; 952():169-74. PubMed ID: 11795437
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients.
Ma H; Brosens LAA; Elias SG; Morsink FHM; Nijman IJ; Hylind LM; Montgomery EA; Offerhaus GJA; Giardiello FM; de Leng WWJ
Sci Rep; 2017 Sep; 7(1):11972. PubMed ID: 28931879
[TBL] [Abstract][Full Text] [Related]
19. Nutrition and colon cancer prevention.
Marshall JR
Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):539-43. PubMed ID: 19512917
[TBL] [Abstract][Full Text] [Related]
20. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
Yang K; Fan K; Kurihara N; Shinozaki H; Rigas B; Augenlicht L; Kopelovich L; Edelmann W; Kucherlapati R; Lipkin M
Carcinogenesis; 2003 Mar; 24(3):605-11. PubMed ID: 12663524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]